Positron Emission Tomography - PET is an imaging technique in which the patient is given a tracer called a radiopharmaceutical, which is the union of a drug or a physiological substance with known pharmacokinetics and pharmacodynamics with a radioactive positron emitting atom. It allows us to correctly evaluate and measure relevant bodily functions: • blood flow • the use of oxygen • the metabolism of sugar (glucose). The most used radiopharmaceutical for carrying out a PET-CT study is Fluordeoxyglucose, whose full name is 2 -fluoro-2-deoxy-Dglucose, but its short form FDG is usually used.
Jasmina I. Alexander S*, Luz Abrego, Melissa Ballesteros, Evenith Campos, Damaris De Leon and Domingo Fernandez
All Published work is licensed under a Creative Commons Attribution 4.0 International License
Copyright © 2018 All rights reserved. iMedPub LTD Last revised : May 25, 2018